Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2009 Nov;21(11):1357-62.
doi: 10.1080/09540120902862576.

The impact of taking or not taking ARVs on HIV stigma as reported by persons living with HIV infection in five African countries

Lucy N Makoae  1 , Carmen J Portillo, Leana R Uys, Priscilla S Dlamini, Minrie Greeff, Maureen Chirwa, Thecla W Kohi, Joanne Naidoo, Joseph Mullan, Dean Wantland, Kevin Durrheim, William L Holzemer
Affiliations
Multicenter Study

The impact of taking or not taking ARVs on HIV stigma as reported by persons living with HIV infection in five African countries

Lucy N Makoae et al. AIDS Care. 2009 Nov.

Abstract

Aim: This study examined the impact of taking or not taking antiretroviral (ARV) medications on stigma, as reported by people living with HIV infection in five African countries.

Design: A two group (taking or not taking ARVs) by three (time) repeated measures analysis of variance examined change in reported stigma in a cohort sample of 1454 persons living with HIV infection in Lesotho, Malawi, South Africa, Swaziland, and Tanzania. Participants self-reported taking ARV medications and completed a standardized stigma scale validated in the African context. Data were collected at three points in time, from January 2006 to March 2007. Participants taking ARV medications self-reported a mean CD4 count of 273 and those not taking ARVs self-reported a mean CD4 count of 418.

Results: Both groups reported significant decreases in total HIV stigma over time; however, people taking ARVs reported significantly higher stigma at Time 3 compared to those not taking ARVs.

Discussion: This study documents that this sample of 1454 HIV infected persons in five countries in Africa reported significantly less HIV stigma over time. In addition, those participants taking ARV medications experienced significantly higher HIV stigma over time compared to those not taking ARVs. This finding contradicts some authors' opinions that when clients enroll in ARV medication treatment it signifies that they are experiencing less stigma. This work provides caution to health care providers to alert clients new to ARV treatment that they may experience more stigma from their families and communities when they learn they are taking ARV medications.

PubMed Disclaimer

Figures

Figure 1
Figure 1
ARV Medication Use and Stigma Over Time
See this image and copyright information in PMC

References

    1. Abadia-Barrero CE, Castro A. Experiences of stigma and access to HAART in children and adolescents living with HIV/AIDS in Brazil. Social Science and Medicine. 2006;62(5):1219–1228. - PubMed
    1. Dlamini PS, Kohi TW, Uys LR, Phetlhu RD, Chirwa ML, Naidoo JR, et al. Verbal and physical abuse and neglect as manifestations of HIV/AIDS stigma in five African countries. Public Health Nursing. 2007;24(5):389–399. - PubMed
    1. Greeff M, Phetlhu R, Makoae LN, Dlamini PS, Holzemer WL, Naidoo JR, et al. Disclosure of HIV status: experiences and perceptions of persons living with HIV/AIDS and nurses involved in their care in Africa. Qualitative Health Research. 2008;18(3):311–324. - PubMed
    1. Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, et al. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19(5):658–665. - PubMed
    1. Holzemer WL, Uys L, Makoae L, Stewart A, Phetlhu R, Dlamini PS, et al. A conceptual model of HIV/AIDS stigma from five African countries. Journal of Advanced Nursing. 2007;58(6):541–551. - PubMed

Publication types

Substances